Antonio Jimenez Jimenez, Associate Professor in the Division of Transplantation and Cellular Therapy at the University of Miami’s Miller School of Medicine shared a post on X:
“Excited to share findings from the multicenter ACCESS trial, supported by CIBMTR and NMDP . PTCy-based GVHD prophylaxis improved survival after MMUD HCT. Grateful for this collaboration advancing equitable transplant access.”
Title: Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Authors: Monzr M. Al Malki, Stephanie Bo-Subait, Brent Logan, Janelle Olson, Jianqun Kou, Sarah Smith, Erin Leckrone, Juan Wu, Heather E. Stefanski, Jeffery J. Auletta, Stephen R. Spellman, Craig Malmberg, Medhat Askar, Rachel Cusatis, Brian C. Shaffer, Dipenkumar Modi, Farhad Khimani, Mahasweta Gooptu, Mehdi Hamadani, Abeer Madbouly, Martin Maiers, Stephanie Fingerson, Rachel Cook, Karen Ballen, Alison Loren, Karilyn Larkin, Sally Arai, Muna Qayed, Sung Won Choi, Larisa Broglie, Bronwen E. Shaw, Steven Michael Devine, Antonio Martin Jimenez Jimenez
